ADS051 is the first and only MRP2 / FPR1 inhibitor to demonstrate favorable safety and tolerability with signals of clinical efficacy with relief from disruptive symptoms of inflammatory bowel disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback